BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35981687)

  • 1. Bidirectional anisotropic palladium nanozymes reprogram macrophages to enhance collaborative chemodynamic therapy of colorectal cancer.
    Chen X; Jia Z; Wen Y; Huang Y; Yuan X; Chen Y; Liu Y; Liu J
    Acta Biomater; 2022 Oct; 151():537-548. PubMed ID: 35981687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
    Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
    Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chirality-Dependent Reprogramming of Macrophages by Chiral Nanozymes.
    Zhang Y; Cui T; Yang J; Huang Y; Ren J; Qu X
    Angew Chem Int Ed Engl; 2023 Aug; 62(34):e202307076. PubMed ID: 37309708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pd@Pt-GOx/HA as a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy.
    Ming J; Zhu T; Yang W; Shi Y; Huang D; Li J; Xiang S; Wang J; Chen X; Zheng N
    ACS Appl Mater Interfaces; 2020 Nov; 12(46):51249-51262. PubMed ID: 33161703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy.
    Li C; Wang L; Li Z; Li Z; Zhang K; Cao L; Wang Z; Shen C; Chen L
    Int J Pharm; 2024 Feb; 651():123729. PubMed ID: 38142016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.
    Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B
    ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia.
    Song M; Liu T; Shi C; Zhang X; Chen X
    ACS Nano; 2016 Jan; 10(1):633-647. PubMed ID: 26650065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of two-dimensional palladium nanozyme activity to enhance chemodynamic/photothermal combined therapy for melanoma.
    Sun D; Liu K; Cheng Y; Sun J; Fang J; Tang Y; Wang F; Guo Y; Wang Y; Chen X
    J Mater Chem B; 2023 Aug; 11(33):7942-7949. PubMed ID: 37539820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Gene-Editable Palladium-Based Bioorthogonal Nanoplatform Facilitates Macrophage Phagocytosis for Tumor Therapy.
    Feng S; Zhang Y; Gao Y; Liu Y; Wang Y; Han X; Zhang T; Song Y
    Angew Chem Int Ed Engl; 2023 Dec; 62(50):e202313968. PubMed ID: 37884479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-covered piezoelectric nanocomposites as tumor microenvironment modulators for piezoelectric catalytic therapy of melanoma.
    Chen C; Yu D; Wang W; Huang Y; Ying Y; Sheng W; Wu X; Wang Y; Gao F; Jiang G
    Int J Biol Macromol; 2023 May; 236():124020. PubMed ID: 36921829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
    Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
    J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose-modified hyaluronic acid nanocapsules for the targeting of tumor-associated macrophages.
    Fernández-Mariño I; Anfray C; Crecente-Campo J; Maeda A; Ummarino A; Teijeiro-Valiño C; Blanco-Martinez D; Mpambani F; Poul L; Devalliere J; Germain M; Correa J; Fernandez-Villamarin M; Allavena P; Fernandez-Megia E; Alonso MJ; Andón FT
    Drug Deliv Transl Res; 2023 Jul; 13(7):1896-1911. PubMed ID: 36472784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanocapsules loaded with poly(I:C) and resiquimod to reprogram tumor-associated macrophages for the treatment of solid tumors.
    Anfray C; Varela CF; Ummarino A; Maeda A; Sironi M; Gandoy S; Brea J; Loza MI; León S; Calvo A; Correa J; Fernandez-Megia E; Alonso MJ; Allavena P; Crecente-Campo J; Andón FT
    Front Immunol; 2023; 14():1334800. PubMed ID: 38259462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment-responsive nanozymes achieve photothermal-enhanced multiple catalysis against tumor hypoxia.
    Lv W; Cao M; Liu J; Hei Y; Bai J
    Acta Biomater; 2021 Nov; 135():617-627. PubMed ID: 34407474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer.
    Jian H; Wang X; Song P; Wu X; Zheng R; Wang Y; Zhang H
    Acta Biomater; 2022 Mar; 140():518-529. PubMed ID: 34923096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Biomimetic Polymer Magnetic Nanocarrier Polarizing Tumor-Associated Macrophages for Potentiating Immunotherapy.
    Liu L; Wang Y; Guo X; Zhao J; Zhou S
    Small; 2020 Sep; 16(38):e2003543. PubMed ID: 32812355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes.
    Jing Z; Li Y; Song J; Zang X
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126912. PubMed ID: 37722648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS Scavenging Nanozyme Modulates Immunosuppression for Sensitized Cancer Immunotherapy.
    Mo W; Liu S; Zhao X; Wei F; Li Y; Sheng X; Cao W; Ding M; Zhang W; Chen X; Meng L; Yao S; Diao W; Wei H; Guo H
    Adv Healthc Mater; 2023 Aug; 12(21):e2300191. PubMed ID: 37031357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer.
    Chen S; He Y; Huang X; Shen Y; Zou Q; Yang G; Fu L; Liu Q; Luo D
    J Nanobiotechnology; 2024 Jun; 22(1):348. PubMed ID: 38898486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.